SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as traders anticipate Phase 3 HOPE-3 data, a potential catalyst for the heavily shorted stock. Discussions revolve around potential data leaks, a possible short squeeze, and the implications of the results for Duchenne muscular dystrophy (DMD) treatment. The community is closely watching for any news, with some expressing concerns about past disappointments and others hoping for a significant price surge if the data is positive.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its community rallies around the revival of OG memes and a return to grassroots community building within the crypto space. Discussions highlight the importance of consistent effort and belief in the project's vision, even amidst market volatility. The community is actively promoting its meme platform and expressing anticipation for broader market improvements, particularly expecting potential catalysts to come from macro events and Bitcoin's performance.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop ($GME) is trending as the community discusses potential catalysts including Michael Burry's GameStop story, Ryan Cohen's moves, and anticipation of the upcoming earnings report. Bullish sentiment seems to be fueled by the company's cash position, activity in warrants, and the collectibles market. Some traders are noting technical indicators and unusual trading patterns, contributing to speculation about a potential breakout.

Bondex is a web 3.0 professional network where users own part of the ecosystem earn rewards and monetise their network.

Bondex

Bondex ($BDXN) is trending with significant volume and price movement, especially after a recent token unlock event that the market absorbed well. The community is actively discussing its strong performance relative to other tokens and the potential for further gains, highlighting positive technical indicators. Bondex's focus on Web3 talent networking and recent acquisitions are also fueling interest.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu is trending as its community, known as the Wolfpack, rallies behind the meme coin, citing strong conviction and a series of upcoming releases. Conversations highlight the community's dedication and the potential for significant growth, drawing comparisons to early-stage Shiba Inu. The community is also excited about the upcoming WolfSwap.

American Eagle Outfitters, Inc. is a multi-brand specialty retailer, which offers an assortment of apparel and accessories for men and women under the American Eagle Outfitters brand, and intimates, apparel and personal care products for women under the Aerie brand. The firm operates stores in the United States, Canada, Mexico, Hong Kong, China and the United Kingdom. It also acquired two emerging brands to complement its existing brands, Tailgate, a vintage sports-inspired apparel brand, and Todd Snyder New York, a premium menswear brand. The company was founded in 1977 and is headquartered in Pittsburgh, PA.

American Eagle Outfitters Inc.

American Eagle Outfitters, Inc.

American Eagle Outfitters is trending after releasing Q3 earnings that beat expectations, leading to a surge in stock price and increased Q4 guidance. The community is focused on holiday sales projections, gross margin improvements, and the continued impact of celebrity endorsements like Sydney Sweeney and Travis Kelce. The stock is also gaining attention as a potential anti-woke investment in the retail sector.

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to a manufacturing milestone announcement regarding its nasal spray product, leading to significant volatility and a surge in trading volume. Community discussions revolve around the stock's potential for a short squeeze and its low float, while some traders express concerns about potential dilution and an impending price drop. The stock's extreme price fluctuations and high trading volume have captured the attention of day traders and investors alike.

Asana, Inc. engages in the business of developing a work management platform that helps organizations orchestrate work from daily tasks to cross-functional strategic initiatives. The company was founded by Dustin Moskovitz and Justin Michael Rosenstein on December 16, 2008 and is headquartered in San Francisco, CA.

Asana Inc - Ordinary Shares - Class A

Asana Inc

Asana's stock is trending due to positive earnings and guidance, with the company achieving cash flow positivity, which is a key talking point among investors. Community members are focused on the potential for a breakout, fueled by bullish options activity and the belief that the market has not yet priced in the company's improved financials. Broader discussions include the company's certifications for global compliance and its unique FedRAMP authorization.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending amid analyst upgrades and discussions around its AI-driven cybersecurity platform. Community members are debating valuation, growth potential, and potential resistance levels. Positive sentiment surrounds its partnerships and position in the cybersecurity sector.

Gitlab, Inc. provides code hosting and collaboration platform services. It offers continuous integration, source code management, out-of-the-box pipelines, agile development, and value stream management. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in Dover, DE.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab is trending amidst discussions of a potential acquisition by Datadog, reportedly at a price over $60 per share, though neither company has confirmed the takeover.  The community is weighing the potential deal, with some analysts expressing skepticism, and debating whether GitLab is undervalued, with some suggesting the stock should be worth significantly more. Despite the unconfirmed rumors, GitLab's strong revenue growth and AI integration remain key points of discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

CPRX or DSNKY: Which Is the Better Value Stock Right Now?

CPRX vs. DSNKY: Which Stock Is the Better Value Option?

Wall Street Analysts Think Catalyst (CPRX) Could Surge 47.37%: Read This Before Placing a Bet

The mean of analysts' price targets for Catalyst (CPRX) points to a 47.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?

Here is how ADC Therapeutics SA (ADCT) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year.

Skandinaviska Enskilda Banken AB publ Trims Stake in Catalyst Pharmaceuticals, Inc. $CPRX

Skandinaviska Enskilda Banken AB publ lessened its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 29.8% in the 2nd quarter, according to its most recent Form 13F...

Carmen Jeffrey Del Sells 10,983 Shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Get Free Report) insider Carmen Jeffrey Del sold 10,983 shares of Catalyst Pharmaceuticals stock in a transaction on Wednesday, November 26th. The shares...

Catalyst Pharmaceuticals (NASDAQ:CPRX) Insider Sells $256,233.39 in Stock

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Get Free Report) insider Carmen Jeffrey Del sold 10,983 shares of the business's stock in a transaction on Wednesday, November 26th. The shares were sold...

Zacks Research Issues Pessimistic Estimate for CPRX Earnings

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) - Research analysts at Zacks Research lowered their Q4 2025 earnings per share (EPS) estimates for Catalyst Pharmaceuticals in a research...

Summit Global Investments Reduces Stake in Catalyst Pharmaceuticals, Inc. $CPRX

Summit Global Investments lessened its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 19.4% in the 2nd quarter, according to the company in its most recent Form...

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.31	--	--	N/A
Q3 '25	$0.33	$0.42	26.51%	BEAT
Q2 '25	$0.39	$0.41	4.59%	BEAT
Q1 '25	$0.34	$0.45	32.35%	BEAT
Q4 '24	$0.34	$0.44	29.96%	BEAT

CPRX
Catalyst Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest CPRX News

CPRXCatalyst Pharmaceuticals Inc